Suppr超能文献

人类布鲁氏菌疫苗的研究进展

Towards a Brucella vaccine for humans.

机构信息

Department of Biomedical Sciences, Defence Science and Technology Laboratory, Porton Down, Salisbury, Wiltshire, UK.

出版信息

FEMS Microbiol Rev. 2010 May;34(3):379-94. doi: 10.1111/j.1574-6976.2010.00211.x. Epub 2010 Jan 19.

Abstract

There is currently no licensed vaccine for brucellosis in humans. Available animal vaccines may cause disease and are considered unsuitable for use in humans. However, the causative pathogen, Brucella, is among the most common causes of laboratory-acquired infections and is a Center for Disease Control category B select agent. Thus, human vaccines for brucellosis are required. This review highlights the considerations that are needed in the journey to develop a human vaccine, including animal models, and includes an assessment of the current status of novel vaccine candidates.

摘要

目前,人类尚无布鲁氏菌病的许可疫苗。现有的动物疫苗可能会导致疾病,因此被认为不适合人类使用。然而,病原体布鲁氏菌是实验室获得性感染最常见的原因之一,也是疾病控制与预防中心 B 类选择剂。因此,需要开发人类布鲁氏菌病疫苗。本综述重点介绍了在开发人类疫苗过程中需要考虑的因素,包括动物模型,并评估了新型疫苗候选物的现状。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验